1. A. Conditional prescribing or prescribing psychologists shall exercise prescriptive authority using psychotropic medications, as defined in Section 61-9-3 NMSA 1978, within the recognized scope of practice of clinical psychopharmacology including the management of side effects and for which the psychologist has been properly educated and trained.
2. B. As provided by Section 61-9-3 NMSA 1978, of the Act when prescribing psychotropic medication for a patient, a conditional prescribing or prescribing psychologist shall maintain an ongoing collaborative relationship with a health care practitioner who oversees the patient’s general medical care to ensure that necessary medical examinations are conducted and significant changes in the patient’s medical or psychological condition are communicated.

3. C. A conditional prescribing or prescribing psychologist shall not treat:

   1. (1) pain disorders, including Somatic Symptom Disorder With Predominant Pain, with opioid narcotics with the exception of buprenorphine;
   2. (2) orthopedic and gynecological illness or disorders;

4. D. A conditional prescribing or prescribing psychologist shall treat psychopharmacologically only behavioral or mental disorders listed in the most recent edition of the diagnostic and statistical manual of mental disorders published by the American Psychiatric Association or most recent version of the International Classification of Diseases (ICD).

   HISTORY OF 16.22.27 NMAC:

   History of Repealed Material:

   16.22.27 NMAC, Conditional Prescribing or Prescribing Psychologists: Formulary, filed 11/15/2006 was repealed and replaced by 16.22.27 NMAC, Conditional Prescribing or Prescribing Psychologists: Formulary, effective 10/08/2024.

[16.22.27.8 NMAC - Rp, 16.22.27.8 NMAC, 10/08/2024]